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Introduction
There is a strong consensus and a belief that a 
lack of controversy exists when comparing enteral 
nutrition (EN) with parenteral nutrition (PN), 
and most experts will report that EN is always 
preferred to PN. Our understanding of the causes 
of malnutrition and the role of artificial nutrition 
in patients with ongoing illness, as quite distinct 
from normal controls, has been evolving for more 
than 50 years [White et al. 2012]. But decisions 
about when to feed, how much to feed, and what 
to feed the undernourished ill are still primarily 
driven by guidelines based on observational data 
and expert opinion. Further, relatively few physi-
cians involved in the decision making related to 
the provision of nutrition support have either 
advanced training or are up to date on current 
thinking and research in nutrition support. This 
results in the persistence of disproven and some-
times deleterious practices, such as favoring PN 
because of the ease with which it can now be 
provided.
This narrative review seeks to provide an objec-
tive overview of the data. The reader is cautioned 
that the authors hold strongly to the belief in the 
superiority of EN over PN. But we also recognize 
that the absence of very well designed, adequately 
powered, prospective, randomized, controlled 
studies, as well as significant changes in clinical 
practices related to and improving the safety of 
providing EN and PN, make possible the reversal 
of this fervently held opinion in the future. In the 
recent Society of Critical Care Medicine and 
American Society for Parenteral and Enteral 
Nutrition guidelines for nutrition support of the 
critically ill, for example, 85% of the guidelines 
were level C or below [McClave et al. 2009].
Because safety, delivery methods, indications, and 
calorie calculations have changed so drastically 
over the past decades for both EN and PN [Casaer 
et al. 2011; Ho et al. 2006; Poulard et al. 2010; 
Slagt et al. 2004], we have elected to focus more 
heavily on recent studies. Pancreatitis, surgery, 
and critical illness are reviewed since most recent 
studies focus on these patient populations. 
Certain studies are discussed to illustrate the 
flaws within them, and the difficulty interpreting 
the available data. Our searches included 
PubMed, the Cochrane Library, and our personal 
files, as well as using references found in review 
articles to construct this review.
Theoretical and basic science 
considerations
Proponents for the use of PN will point out that 
EN delivers calories much less reliably than PN, 
suggesting this is deleterious. There is no question 
that chronic starvation will cause harm. But there 
have been consistently better outcomes in the 
patients who receive EN (Table 1).
There are a large number of animal studies dem-
onstrating physiological differences between ani-
mals receiving EN versus PN. These have led to 
the conclusion that food in the gut has an impor-
tant role in preserving normal physiology, espe-
cially that related to immune function and systemic 
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inflammation. It is postulated that PN is less 
favorable because patients not only lack the bene-
fits from food in the gut, but that PN may also 
induce deleterious changes in physiology. Research 
in this area has elucidated a number of important 
pathways in immunology and systemic inflamma-
tion. As a result, there is growing evidence that 
septic shock syndrome may not be due to bactere-
mia, but rather due to an interaction between acti-
vated pathogenic microorganisms in the gut and 
the mucosal cells to which they bind. These cells 
in turn secrete the inflammatory mediators 
responsible for the syndrome [Alverdy et al. 2003]. 
Some other interesting examples of animal studies 
follow.
Kudsk and colleagues provide data that mice have 
a significant decrease in production of pulmonary 
immunoglobulin A when on PN versus EN. 
Further, mice immunized against influenza and 
placed on PN have a 60% rate of viremia when 
exposed to influenza virus. Immunized mice, ini-
tially on PN and then returned to oral diet, had 
zero viremia on exposure [Kudsk et al. 1996]. 
Human clinical data suggested that there is a pro-
tective effect on the lung when patients receive 
EN, compared with nothing, early after surgery. 
In some reviews of studies of early postoperative 
feeding, there is a trend toward a reduction in 
pneumonia despite a concurrent trend toward an 
increase in vomiting [Lewis et al. 2001].
Omata and colleagues showed that mice on PN 
had fewer hepatic mononuclear cells, decreased 
expression of lipopolysaccharide receptors, and 
decreased survival after intraperitoneal injection 
of Pseudomonas. Resumption of an oral diet 
reversed both the immune alterations and the 
decrease in survival [Omata et al. 2009].
In an experimental burn model in guinea pigs, 
Saito and colleagues found that those fed enterally 
had better nitrogen balance and preservation of 
weight, lower plasma stress hormone levels, and 
greater mucosal weight and thickness [Saito et al. 
1987]. Human studies have shown a reduction in 
jejunal villous height in normal volunteers placed 
on PN and nil by mouth for 2 weeks [Buchman 
et al. 1995]. In a study of critically ill patients, 
intestinal mucosa was atrophic and leakier than in 
normal volunteers after 4 days without nourish-
ment [Hernandez et al. 1999]. Mucosal leakage of 
bacterial antigens has been examined as a cause for 
hepatic fibrosis in hepatic cirrhosis, for the 
increased inflammatory state in the obese, and as 
an alternative to the mucosal adherence theory of 
septic shock syndrome mentioned above.
Scientific constraints
The meaningful comparison of EN and PN is dif-
ficult. There are physiological differences between 
enteral and parenteral delivery of nutrients for 
which control is challenging. It is virtually impos-
sible to blind a nutrition support study. Appropriate 
nutritional clinical outcomes are mortality, mor-
bidity/quality of life, and cost of care [Koretz, 
2005; Seres, 2005], which require large studies for 
adequate power. Easy to measure surrogates, such 
as serum proteins and anthropometrics, are no 
longer considered reliable indicators of adequacy 
of nourishment in the ill. These surrogates are 
excellent predictors of outcome. However, sys-
temic inflammation rather than artificial nourish-
ment is the major determinate of changes in these 
surrogates [Koretz, 2005; Seres, 2005].
For one therapy to be considered more ‘beneficial’ 
than another, it must be first established that one 
or the other has benefit compared with no inter-
vention. Otherwise, findings of differences may 
only indicate that one intervention is less detri-
mental than the other. Nutrition outcomes studies 
are notoriously difficult to perform; there are no 
expensive drugs creating funding pathways, and as 
mentioned, the numbers of patients required to 
adequately power studies of outcome differences 
is quite large. The result is a large number of low-
quality underpowered studies. Further, institu-
tional review boards are loath to allow continued 
lack of nourishment in patients with preexisting 
malnutrition. Therefore, most studies comparing 
artificial nutrition with no intervention, the only 
true controlled trial, exclude patients most likely 
to benefit: those with malnutrition. In the aggre-
gate, and using strict evidence-based analysis, we 
have yet to truly prove when it is that artificial 
Table 1. Examples of theoretical reasons for benefits 
of enteral nutrition.
Preservation of mucosal architecture
Preservation of gut associated lymphoid tissue (GALT)
Preservation of hepatic immune function
Preservation of pulmonary immune function
Reduction of inflammation
Reduction of antigenic leak from gut
Interference with pathogenicity of gut organisms
Less hyperglycemia
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nutrition has clinical outcomes benefits over no 
intervention [Koretz et al. 2001, 2007].
The assertion that EN is ‘safer’ than PN requires 
data on the complication rates associated with 
both intravenous catheter as well as feeding device 
insertion. In an earlier analysis, Lipman com-
mented that there are multiple potential compli-
cations resulting from placement of access for 
EN, including nasopulmonary intubation, esoph-
ageal stricture and perforation, intestinal obstruc-
tion or perforation, abdominal wall migration of 
tubes, and bowel necrosis and death associated 
with surgical jejunostomies [Lipman, 1988]. He 
concluded that, in the absence of documented 
evidence demonstrating lower EN complication 
rates compared with PN, EN cannot be said to be 
safer than PN [Lipman, 1998]. In a subsequent 
review, McClave and Chang reported that the 
overall complication rate for percutaneous endo-
scopic gastrostomy tube placement ranged from 
4.9% to 10.8%, but complications were more 
common in patients who had malnutrition or 
advanced cancer [McClave and Chang, 2003]. 
These complications may be infrequent and not 
lead to high mortality, but without comparison 
data, the possibility that their morbidity may 
exceed that of central catheters and PN must be 
considered. Lipman observed that there were no 
deaths from catheter infections, but severe mor-
bidity from enterostomy insertion in his institu-
tion [Lipman, 1998]. Further, there are no recent 
data, as far as the authors are aware, that reevalu-
ates complication rates from these procedures.
EN is variably defined, but in general, it provides 
nourishment into the gut, and may include diet, 
oral supplementation, and feeding via a tube. For 
this analysis, the studies reported include patients 
being fed by tube, except when noted otherwise.
PN includes nourishment by central and periph-
eral veins. Only studies providing PN via a central 
venous catheter (central PN or CPN) were 
included. The terminology ‘total’ PN (TPN) is 
often used to connote CPN, but this can be mis-
leading. PN provided by a peripheral vein, so 
called peripheral PN (PPN), can provide total 
nutrient needs if the patient can tolerate the vol-
ume required. Since the route, and not the ade-
quacy of nourishment, was the defining quality for 
inclusion of studies in this report, all PN referred 
to is CPN. Studies using PPN are unusual and 
none were recent or deemed of the required qual-
ity for inclusion.
Enteral nutrition and parenteral nutrition: 
recent developments
There have been significant improvements in the 
care of patients receiving EN and PN. New analy-
ses are required to understand the impact of these 
on complication rates in both PN and EN. Safe 
practice guidelines for PN have been published 
[Mirtallo et al. 2004], but adherence is poor 
[Boullata et al. 2012; Seres et al. 2006]. Safety 
interventions have resulted in significantly 
reduced infection rates for central venous cathe-
ters [Pronovost, 2008], and the acceptable rate is 
now zero in hospitalized patients [Kuhn, 2008]. 
This might, in theory, improve the safety of PN, 
since an increase in infections in patients receiv-
ing PN is the most common difference cited 
between PN and EN [Klein and Koretz, 1994; 
Lipman, 1998]. Conversely, Casaer and col-
leagues have recently published a large, rand-
omized multicenter study in which early initiation 
of PN was compared with delayed (1 week) initia-
tion when EN was insufficient in critically ill 
patients [Casaer et al. 2011]. They report a 6.3% 
likelihood of earlier discharge from the ICU [haz-
ard ratio 1.06; 95% confidence interval (CI) 
1.00–1.13; p = 0.04] and from the hospital (haz-
ard ratio 1.06; 95% CI 1.00–1.13; p = 0.04), with 
fewer infections in the late-initiation group 
(22.8% versus 26.2%, p = 0.008), 3 days less dial-
ysis (p = 0.008), and a reduced cost for the hospi-
talization of approximately US$1600 (p = 0.04)
[Casaer et al. 2011].
However, improvements in safety and conditions 
in which use of EN is accepted, as well as improved 
ease of access, have significantly broadened the 
definition of a ‘functioning gut’ into which EN 
can be infused. Protocols are being refined to 
improve safety and tolerance [Heyland et al. 
2002]. Small bowel access for patients with gas-
tric dysfunction may now be performed blindly at 
the bedside [Slagt et al. 2004]. Endoscopic place-
ment of percutaneous jejunostomies, percutane-
ous dual tube gastrojejunostomies, and nasojejunal 
tubes has become commonplace with good safety 
records [Freeman and Delegge, 2009]. Dual port 
nasogastrojejunal tubes, which drain the stomach 
and feed into the jejunum, are an option for 
patients with pancreatitis and duodenal obstruc-
tion due to compression from a phlegmon 
[O’Keefe et al. 2012] or with other types of gastric 
dysfunction.
Jejunal feeding, which had initially been thought to 
reduce aspiration, is likely not necessary in many 
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critically ill patients [Ho et al. 2006], making 
enteral access much easier. Vomiting and aspira-
tion have long been a concern, without foundation 
in data, for tube-fed critically ill patients. 
Significantly higher gastric residual volumes 
(GRVs) are now accepted [Montejo et al. 2010]. 
Some authors have recommended against their use 
entirely. Poulard and colleagues found similar out-
comes and higher feed volume delivery when they 
compared patients before (n = 102) and after 
(n = 103) they ceased checking GRVs in mechani-
cally ventilated patients in a mixed medical–surgical 
intensive care unit (ICU) [Poulard et al. 2010]. 
Intolerance (high GRV and vomiting in control 
group, vomiting in intervention group) was much 
lower once GRVs were no longer checked (26% 
post versus 46% pre, p = 0.004). The rate of vomit-
ing alone was no different in the two groups (26% 
post versus 25% pre, p = 0.34). Ventilator-associated 
pneumonia occurred with the same frequency in 
the two groups (18% post versus 20% pre, p = 
0.86). There was also a significantly larger volume 
of feeding delivered to the patients after GRV test-
ing was stopped [1489 ml, interquartile range 
(IQR) 1349–1647 post versus 1381, IQR 1151–
1591 pre; p = 0.002) [Poulard et al. 2010]. It should 
be noted that the rates of both vomiting and pneu-
monia in these patients are quite high relative to 
our experience.
Other conditions, which were traditional indica-
tions for PN, have been reported to be amenable 
to EN. For example, anastomotic leaks with 
severe intraperitoneal sepsis have now been suc-
cessfully treated with stents and an oral diet 
resumed shortly after [Babor et al. 2009]. Others 
have reported successful management of patients 
with anastomotic leaks after gastrectomy for can-
cer using feeding via fluoroscopically placed 
nasointestinal tube [Akashi et al. 2012]. There 
have been several reports of select patients with 
chyle leak being managed with EN [Smoke and 
Delegge, 2008]. Further, it has been suggested 
that for patients with chyle leaks, low long-chain 
fat nutrition is attempted first and then PN 
started if the leak fails to close [de Gier et al. 
1996]. However, there are too few patients 
reported to analyze outcomes in these patients 
[Smoke and Delegge, 2008].
Enteral nutrition versus parenteral 
nutrition in pancreatitis
EN has been favored for some time for patients 
with pancreatitis requiring some form of nutrition 
support. Four systematic reviews with meta- 
analyses of randomized trials comparing EN with 
PN in patients with pancreatitis have been pub-
lished since 2008. All find in favor of EN 
[Al-Omran et al. 2010; Petrov et al. 2008; Petrov 
and Whelan, 2010; Yi et al. 2012]. Three focus 
solely on severe acute pancreatitis [Petrov et al. 
2008; Petrov and Whelan, 2010; Yi et al. 2012], 
and the fourth, from the Cochrane Colla-
borative by Al-Omran, on pancreatitis in general 
[Al-Omran et al. 2010]. Two of the reports on 
severe pancreatitis, each with five studies included, 
had the same first author, Petrov, and differed by 
one paper, but had different focuses [Petrov et al. 
2008; Petrov and Whelan, 2010]. The more recent 
analysis by Yi and colleagues included eight 
studies, and added two more recent studies not 
included in either Petrov analysis [Yi et al. 2012]. 
The Cochrane analysis [Al-Omran et al. 2010] 
also included eight studies, but only five were 
common to the prior analyses. All of the 11 evalu-
ated studies were technically flawed (Table 2).
In the first Petrov analysis (EN = 95 patients, PN 
= 107), the authors report statistically signifi-
cantly fewer infectious complications in EN 
patients [22% versus 43%; relative risk (RR) 0.47; 
95% CI 0.28–0.77; p < 0.001], pancreatic infec-
tions (RR 0.48; 95% CI 0.26–0.91; p = 0.02), 
need for surgery (RR 0.37; 95% CI 0.21–0.65; 
p = 0.001), and mortality (4% versus 16%; RR 
0.32; 95% CI 0.11–0.98; p = 0.03)[Petrov et al. 
2008]. In his second analysis, which included 
Table 2. Overview of outcomes: enteral versus parenteral nutrition in pancreatitis (↓= statistically significant 
decrease with enteral nutrition).










Petrov et al. [2008] ↓ ↓ ↓ ↓  
Yi et al. [2012] ↓ ↓ ↓ ↓  
Al-Omran et al. [2010] ↓ ↓ ↓ ↓ ↓ ↓
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92 patients receiving PN and 82 on EN, Petrov 
focused only on complications attributable to each 
nutrition modality [Petrov and Whelan, 2010]. In 
that report, patients receiving EN had more diar-
rhea [23% versus 7%; odds ratio (OR) 0.2; 95% 
CI 0.09–0.43; p < 0.001], patients receiving PN 
had more hyperglycemia (23% versus 11%; OR 
2.59; 95% CI 1.13–5.94; p = 0.03), but no out-
comes were reported [Petrov and Whelan, 2010].
In the subsequent analysis, Yi and colleagues 
included a significantly larger patient pool (184 
EN, 197 PN), and found patients receiving EN to 
have markedly lower mortality (8.2% versus 
24.3%; p = 0.001), infectious complications (26% 
versus 56%; p = 0.02), organ failure (16% versus 
47%; p = 0.02), and need for surgery (19% versus 
53%; p = 0.003) [Yi et al. 2012].
Finally, Al-Omran and colleagues found a marked 
reduction in death in a total of 348 subjects (RR 
0.50; 95% CI 0.28–0.91), multiple organ failure 
(RR 0.55; 95% CI 0.37–0.81), systemic infection 
(RR 0.39; 95% CI 0.23–0.65), need for surgery 
(RR 0.44; 95% CI 0.29–0.67), local septic com-
plications (RR 0.74; 95% CI 0.40–1.35), and 
length of stay (reduced by 2.37 days; 95% CI 
–7.18 to 2.44) for patients receiving EN. In a sub-
group analysis of patients with severe pancreatitis, 
the risk of death (RR 0.18; 95% CI 0.06–0.58) 
and multiple organ failure (RR 0.46; 95% CI 
0.16–1.29) was even more dramatically decreased 
[Al-Omran et al. 2010].
In summary, the weight of the evidence strongly 
favors EN over PN for patients with pancreatitis 
who require artificial nutrition, with less mortal-
ity, fewer infections, less need for surgery, a lower 
incidence of multiple organ failure, and shorter 
length of stay in patients receiving EN versus those 
receiving PN.
Enteral nutrition versus parenteral 
nutrition in surgical patients
After pancreaticoduodenectomy
Because of the high incidence of postoperative 
gastric dysfunction in patients undergoing pan-
creaticoduodenectomy (whipple) for cancer of 
the pancreas, feeding enterostomies are often 
placed intraoperatively. There are limited data of 
poor quality to drive recommendations for 
preemptive tube placement in this population. In 
a retrospective analysis which included 1873 
patients in the California Cancer Registry from 
1994 to 2003, Yermilov and colleagues found an 
association between the severity of the score on a 
comorbidity index and whether patients received 
PN [Yermilov et al. 2009]. Patients who received 
PN (14% of patients) also had a longer length of 
stay. However, patients who receive PN at the dis-
cretion of their clinician (as opposed to via rand-
omization) are usually sicker to begin with, and 
sicker patients have longer lengths of stay. 
Similarly, patients in this cohort receiving feeding 
jejunostomies at the time of surgery were more 
likely to be sicker or have a more advanced cancer 
stage. There were 56 patients who had insertion 
of feeding jejunostomies who then received PN 
and were excluded in the statistics. This suggests 
an approximate 11% failure rate for enteral feed-
ing. This would also bring the incidence of 
patients requiring PN to 17%. It is not reported 
how many of the 23% of patients who had place-
ment of jejeunostomies at the time of surgery 
actually required their use. But at worst, if all of 
the patients who had jejunostomies placed 
required their use, a maximum of 40% of all 
patients received nutrition support. At best, only 
17% needed nutrition support if none of the jeju-
nostomies were required. Further, the ‘need’ for 
nutrition support was inversely related to the 
number of cases done in each institution [Yermilov 
et al. 2009], suggesting a lack of uniformity of 
indications for insertion.
In an historical control study, Georgakis and col-
leagues report the outcomes prior to (n = 25) and 
after (n = 34) stopping a policy of universal place-
ment of surgical feeding gastrojejunostomies at 
the time of pancreaticoduodenectomy [Georgakis 
et al. 2012]. They report no change in outcomes, 
other than a significant decrease in total compli-
cations (56% versus 35%; p = 0.09) and length of 
stay (14 days versus 11 days; p = 0.09) once all 
patients stopped automatically receiving the feed-
ing tubes. Further, the need for PN was not dif-
ferent in the two groups. This is an admittedly 
underpowered study, but speaks to the possibility 
that insertion of feeding tubes may not be benign, 
and should not be assumed safe unless studied 
properly [Georgakis et al. 2012].
In contrast, Liu and colleagues report the results 
of a prospective randomized clinical trial in which 
60 patients were randomized to receive a jejunos-
tomy and early enteral feeding versus  PN. Patients 
received the nutritional modality for a minimum 
of 6 days. They found no difference in incidence 
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of intra-abdominal infections, liver dysfunction, 
biliary fistulas, or lung infections between the 
groups. In enterally fed patients, however, there 
were significantly fewer patients with upper gas-
trointestinal hemorrhage (nine PN versus one EN; 
p = 0.021), delayed gastric emptying (six PN ver-
sus zero EN; p = 0.039), and pancreatic fistulas 
(eight PN versus one EN; p = 0.039). There was 
no difference in hospital length of stay, and there 
were no deaths in either group [Liu et al. 2011].
In another small study by Park and colleagues (38 
patients randomized), patients were fed either 
parenterally or enterally via nasojejunal tube 
beginning on postoperative day 1 and until oral 
intake was more than 800 kcal. Patients receiving 
early EN had earlier bowel movements (2.5 days; 
p = 0.041), were on a regular diet sooner (0.7 days; 
p = 0.020), and had regained their perioperative 
weight loss by day 21. Patients who received PN 
continued to lose weight for 90 days postopera-
tively [Park et al. 2012].
In the aggregate, there are insufficient data to 
drive evidence-based recommendations specifi-
cally for patients undergoing pancreaticoduo-
denectomy. There are observational data 
suggesting that there may be aggregate risk asso-
ciated with universal placement of feeding enter-
ostomies in all patients undergoing this procedure. 
In our institution, an attempt was made to find 
characteristics that would predict which patients 
would need jejunostomies, but no statistically sig-
nificant relationships were found (Chabot, 2012, 
personal communication).
Surgery of the head, neck, and esophagus
In a prospective randomized clinical trial, Ryu 
and colleagues assigned 81 patients undergoing 
laryngeal and pharyngeal cancer surgery in Korea 
to receive either EN via nasogastric tube or PN 
postoperatively. Only patients who required sup-
port for at least 1 week were included in the anal-
ysis. Patients receiving EN had a nonsignificant 
increase in incidence of pneumonia (9.8% versus 
0.0%; p = 0.06) but all recovered well. There was 
one episode of line sepsis in the PN group. Other 
than cost (estimated savings comparing product 
and equipment of US$12/day, plus US$20 per 
insertion; statistical analysis not provided), there 
were no other significant differences between the 
groups [Ryu et al. 2009]. In studies such as this, 
with a small number of patients, short duration 
of therapy, and relative good health of the 
patients, it is not unexpected for differences to be 
undetectable.
In another small study of 30 patients randomized 
to EN or PN for 7 days after esophagectomy, 
Seike and colleagues found no difference in leak 
rate, inflammatory markers, or albumin [Seike 
et al. 2011]. However, in a larger (154 patients) 
randomized trial, Fujita and colleagues found a 
significantly lower rate of total life-threatening 
complications in those receiving EN via nasoje-
junal tube (30.6% PN versus 15.7% EN; 
p = 0.02) [Fujita et al. 2012]. It is not clear how 
patients were randomized, and the description of 
the PN is also confusing and may in fact have 
been peripheral. In addition, a power analysis is 
not discussed. Regardless, there were trends 
toward fewer episodes of anastomotic leak 
(19.3% PN versus 10.5% EN; p = 17) and pneu-
monia (11.3% PN versus 5.2% EN; p = 0.26). 
There was also a significant improvement in the 
ability to complete the clinical management plan 
in EN patients (63.6% PN versus 77.6% EN; 
p = 0.03) and a reduction in hospital length of 
stay (19 days PN versus 16 days EN; p = 0.04) 
[Fujita et al. 2012].
General surgery
The benefit of EN over PN in general surgery 
patients has long been recognized. In a 1992 
meta-analysis, Moore and colleagues report on 
230 patients randomized to EN or PN. There 
were significantly fewer septic complications in 
the EN patients (16% EN versus 35% PN; p = 
0.01) and significantly more hyperglycemia in the 
PN patients (p < 0.05) [Moore et al. 1992]. It 
should be noted that the majority of the patients 
included in this analysis had never been published 
in peer-reviewed journals, and it appears that the 
authors incorporated data from two additional 
studies into a meta-analysis to allow for data from 
a multicenter study to have statistically significant 
results.
In a study by Braga and colleagues, 257 patients 
were randomized to receive EN or PN postop-
eratively after undergoing surgery for cancer of 
the upper gastrointestinal tract, including stom-
ach, pancreas, and esophagus. EN was started 
6 h after surgery and PN on postoperative day 1. 
There were no differences in any outcomes 
measured, which included many serum markers 
and clinical complications. There was, however, 
a fourfold cost for PN compared with EN 
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(US$90.60/day for PN, US$25/day for EN; p < 
0.001) [Braga et al. 2001].
In a follow-up study, which may be the best 
designed study of its kind, with appropriate ran-
domization and power, 317 patients with preexis-
iting malnutrition (≥10% weight loss) were 
randomized to EN or PN following gastrointesti-
nal resection for cancer. Surgery included upper 
and lower gastrointestinal procedures. In the EN 
group, 34 patients (21%) were intolerant of the 
goal feed rate, and of these, 14 were switched to 
PN. Adverse minor events, such as abdominal 
distention, cramps, diarrhea, and vomiting were 
significantly higher in the EN group (35% EN 
versus 14% PN; p < 0.0001). However, there were 
statistically significant reductions in infectious 
complications (16% EN versus 27% PN; 
p = 0.018) and overall complications (34% EN 
versus 49% PN; p = 0.005) in the EN group 
[Bozzetti et al. 2001].
In a recent ‘best practice’, structured protocol 
review, Wheble and colleagues reviewed seven 
evaluable studies. They report that there were 
many technical problems with the quality of all of 
the studies, but at worst early EN after gastroin-
testinal surgery is a ‘suitable alternative’ to PN, 
appears to reduce length of hospital stay and time 
to resumption of normal bowel function relative 
to PN, and is far less expensive. They conclude 
that EN ‘should be considered as the preferred 
method for delivery of postoperative nutrition’ 
[Wheble et al. 2012].
Trauma
EN, particularly when started early, has long been 
promoted as the preferred route in patients who 
have sustained severe trauma and undergo sur-
gery. The trauma group at the University of 
Washington in Seattle published one of the first 
randomized trials comparing EN with PN in 
1986. They found that average daily calorie intake, 
nitrogen balance, and complication rates were 
comparable between the two groups (46 total 
patients). Both groups had jejunostomy and cen-
tral venous access placed [Adams et al. 1986]. In 
1992, the trauma group at the University of 
Tennessee, Memphis performed a larger study in 
which all 98 patients again received jejunostomies 
during surgery for blunt and penetrating abdomi-
nal trauma, regardless of whether they were rand-
omized to EN or PN. Patients randomized to EN 
had less pneumonia (11.8% EN versus 31% PN; 
p < 0.02), significantly fewer intraabdominal 
abscesses (1.9% EN versus 13.3% PN; p < 0.04), 
a lower incidence of line-related sepsis (1.9% EN 
versus 13.3% PN; p < 0.05), a decreased rate of 
infections overall (0.4 infections/patient EN ver-
sus 1.2 infections/patient PN; p = 0.03), and fewer 
infections per infected patient (1.0 EN versus 1.6 
PN; p < 0.01) [Kudsk et al. 1992].
More recently, a multicenter (eight centers) group 
reported on a large retrospective cohort study of 
patients who sustained severe blunt trauma and 
compared those receiving EN with those receiv-
ing early supplemental PN when intolerant to 
EN. There was a significantly higher infection rate 
in the supplemental PN group. The groups, how-
ever, were clinically quite different. The group 
intolerant to EN and receiving early PN were 
sicker based on having received many more units 
of blood (2300 ml versus 1500 ml; p < 0.001), hav-
ing higher abdominal abbreviated injury scores 
(189 versus 52; p = 0.008), and a greater need for 
laparotomy (191 versus 56 patients; p = 0.001). 
Strangely, they also had lower Acute Physiology 
and Chronic Health Evaluation II scores (28 ver-
sus 33; p < 0.001) [Sena et al. 2008]. With this lack 
of uniformity of the clinical states of the compari-
son groups, it is likely that selection bias is com-
pounding the outcomes of this observation.
In conclusion, in a variety of groups of surgical 
patients, EN has been shown to be superior to 
PN, and should be the first line of intervention 
when surgical patients require nutrition support. 
Wholesale concerns about anastomotic leakage 
due to feeding are unfounded, although surgeon’s 
discretion may require a tenuous anastomosis to 
be rested in selected cases. The number of post-
operative conditions in which EN has been shown 
to be preferred is growing, and the data support-
ing the expanding interest in feeding early are 
increasing. For example, our Department of 
Urology is currently conducting a multicenter 
study of early feeding (as soon as the patient 
wants to eat, usually within 24 h) versus delayed 
feeding (after bowel sounds and flatus, usually 
3–5 days) after radical cystectomy and ilial con-
duit [Deibert, 2011].
Critical illness
An excellent systematic review with meta- 
analysis was performed by Gramlich and col-
leagues on 13 qualifying studies of mixed 
critically ill patients. They found a significant 
Therapeutic Advances in Gastroenterology 6 (2)
164 http://tag.sagepub.com
decrease in infectious complications in patients 
receiving EN versus PN (RR 0.64; 95% CI 0.47–
0.87; p = 0.004). There was no difference in 
mortality, days on ventilator, or length of hospi-
tal stay. Four of the studies reported decreased 
cost, but this was not analyzed for statistical sig-
nificance [Gramlich et al. 2004]. A second analy-
sis that year reviewed five studies in which EN 
was compared with a combination of EN and 
PN. PN was added to EN to insure a desired 
level of calorie delivery, or EN was added to PN 
to attenuate the perceived deleterious effects of 
PN. Most of the patients were well nourished. 
The authors found no difference in infectious 
complications or hospital stay, and suggest that 
the addition of PN in this population is unneces-
sary [Dhaliwal et al. 2004].
Two recent studies have improved our under-
standing of the utility of these feeding modali-
ties in the ICU. One trial, by Casaer and 
colleagues, was discussed earlier in this paper. 
In this study, 2640 patients were randomized to 
receive either PN within 48 h of ICU admission 
(early PN), or after 8 days, if EN was not deliv-
ering adequate calories. Early EN was started in 
both groups. In the early PN group, PN pro-
vided calories in addition to EN to reach calorie 
goal within 3 days of ICU admission. To review, 
there were fewer infections and decreased chol-
estasis, fewer patients requiring more than 2 
days of mechanical ventilation, and fewer days 
of renal replacement therapy, with reduced 
overall costs in the patients for whom PN was 
delayed [Casaer et al. 2011]. In the EDEN trial, 
patients were randomized within 48 h of ICU 
admission to receive either low-volume ‘trophic’ 
enteral feeds or full ‘goal’ feeds for the first 
week. There were no differences in outcomes 
between the groups, and the only significant dif-
ference was an increase in gastrointestinal intol-
erance in the early full feed group [National 
Heart, Lung and Blood Institute Acute 
Respiratory Distress Syndrome Clinical Trials 
Network et al. 2012].
In summary, there appears to be evidence that 
EN is preferred to PN in patients in ICUs, but 
that achieving goal feed rate, or goal calories, is 
not urgent, at least for the first week, and may 
be detrimental if accomplished by addition of 
PN.
Conclusions
Nutrition support research is often difficult to 
interpret due to the challenges achieving ade-
quate study size and quality. However, in a vari-
ety of patient populations, the preponderance of 
data supports the benefits of choosing EN over 
PN when patients require nutrition support 
(Table 3). Physicians involved in decision making 
related to nutrition support should be aware of 
current research and clinical guidelines, and 
more physicians should seek advanced training in 
nutrition support.
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